Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients

被引:25
作者
Nakashima, A. [1 ,2 ,3 ]
Carrero, J. J. [2 ,3 ,4 ]
Qureshi, A. R. [2 ,3 ]
Hirai, T. [5 ]
Takasugi, N. [5 ]
Ueno, T. [1 ]
Taniguchi, Y. [6 ]
Lindholm, B. [2 ,3 ]
Yorioka, N. [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Adv Nephrol, Minami Ku, Hiroshima 7348551, Japan
[2] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Baxter Novum, Stockholm, Sweden
[4] Karolinska Inst, Ctr Gender Med, Stockholm, Sweden
[5] Hakuai Clin, Dept Internal Med, Kure, Japan
[6] Hiroshima Int Univ, Dept Pharmaceut Sci, Div Clin Pharmacotherapeut, Kure, Japan
关键词
Cardiovascular disease (CVD); Hemodialysis (HD); Mortality; Osteoprotegerin (OPG); Pulse wave velocity (PWV); CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; SERUM OSTEOPROTEGERIN; ELEVATED OSTEOPROTEGERIN; RISK-FACTORS; OSTEOCLASTOGENESIS; OSTEOPOROSIS; INFLAMMATION; DENSITY; IMPACT;
D O I
10.1007/s00198-010-1377-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A high circulating osteoprotegerin (OPG) level may be a risk factor for vascular calcification and mortality in hemodialysis patients. OPG and pulse wave velocity (PWV) were measured at baseline in 151 normoalbuminemic, long-term (> 3 years) Japanese hemodialysis patients who were prospectively followed for 6 years. In long-term normoalbuminemic Japanese hemodialysis patients, OPG levels were strongly linked with both arterial stiffness and worse outcome. A high circulating OPG level is reported to be a risk factor for vascular calcification and mortality in Western chronic kidney disease (CKD) patients but it is not known if this is true for Japanese CKD patients, where a different risk profile may operate. OPG and PWV were measured at baseline in 151 normoalbuminemic, long-term (> 3 years) Japanese hemodialysis patients (median age 62 years) who were prospectively followed for 6 years. OPG levels were associated in multivariate analysis with age, dialysis vintage, history of cardiovascular disease (CVD) and parathyroid hormone levels. C-reactive protein levels did not correlate with OPG. Patients with clinical history of CVD had significantly higher OPG levels and OPG levels were positively correlated to PWV, an index of arterial stiffness. These associations were independent of age, sex, dialysis vintage, and diabetes. During the follow-up period, 40 deaths, including 25 cardiovascular deaths, were recorded. In crude analysis, each unit of increase in OPG was associated with increased all-cause (hazard ratios 1.14, 95% confidence interval 1.08-1.20) and CVD mortality (1.14 [1.07-1.21]), which persisted after adjustment for age, sex, dialysis vintage, diabetes, and baseline CVD (1.12 [1.05-1.19] and 1.11 [1.02-1.19], all-cause and CVD mortality, respectively). In long-term normoalbuminemic Japanese hemodialysis patients, with low prevalence of inflammation, OPG levels were strongly linked with both arterial stiffness and worse outcome.
引用
收藏
页码:1695 / 1701
页数:7
相关论文
共 27 条
  • [1] Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
    Barreto, DV
    Barreto, FC
    Carvalho, AB
    Cuppari, L
    Cendoroglo, M
    Draibe, SA
    Moyses, RMA
    Neves, KR
    Jorgetti, V
    Blair, A
    Guiberteau, R
    Canziani, MEF
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (04) : 1576 - 1582
  • [2] Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease
    Blacher, J
    Demuth, K
    Guerin, AP
    Safar, ME
    Moatti, N
    London, GM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) : 535 - 541
  • [3] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [4] Vascular calcifications:: Pathogenesis, management, and impact on clinical outcomes
    Cannata-Andia, Jorge B.
    Rodriguez-Garcia, Minerva
    Carrillo-Lopez, Natalia
    Naves-Diaz, Manuel
    Diaz-Lopez, Bernardino
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 : S267 - S273
  • [5] Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease: A Hypothesis Proposal
    Carrero, Juan Jesus
    Stenvinkel, Peter
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 : S49 - S55
  • [6] COODKIN DA, 2003, J AM SOC NEPHROL, V14, P3270
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions
    Heinzl, H
    Kaider, A
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1997, 54 (03) : 201 - 208
  • [9] Assessment of Myeloperoxidase and Oxidative α1-Antitrypsin in Patients on Hemodialysis
    Honda, Hirokazu
    Ueda, Masashi
    Kojima, Shiho
    Mashiba, Shinichi
    Hirai, Yuki
    Hosaka, Nozomu
    Suzuki, Hiroki
    Mukai, Masanori
    Watanabe, Makoto
    Takahashi, Keiko
    Shishido, Kanji
    Akizawa, Tadao
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01): : 142 - 151
  • [10] Kazama JJ, 2005, CLIN NEPHROL, V64, P64